Published in Ann Surg on November 01, 1991
Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg (2005) 1.47
Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg (2002) 1.15
Wound complications after inguinal lymph node dissection for melanoma: is ACS NSQIP adequate? Ann Surg Oncol (2013) 1.00
The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg (2007) 0.98
Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbecks Arch Surg (2003) 0.85
Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors. World J Surg Oncol (2013) 0.83
Adjuvant radiation therapy in metastatic lymph nodes from melanoma. Radiat Oncol (2011) 0.82
Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM. Ann R Coll Surg Engl (2011) 0.79
Multiplying therapies and reducing toxicity in metastatic melanoma. Cancer Biol Ther (2015) 0.79
A tale of two pities: autologous melanoma vaccines on the brink. Hum Vaccin Immunother (2012) 0.78
Parametric modeling of localized melanoma prognosis and outcome. J Biopharm Stat (2009) 0.78
Sentinel node studies in truncal melanoma: does an increased number of draining basins correlate with an increased risk of lymph metastasis? Cancer Imaging (2012) 0.75
Management of Conjunctival Melanoma: Critical Assessment of Sentinel Lymph Node Biopsy. Ocul Oncol Pathol (2015) 0.75
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer (1975) 4.12
Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg (1990) 2.27
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg (1977) 1.27
Prognostic value of lymph node dissection in malignant melanoma. Arch Surg (1980) 1.24
Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg (1982) 1.15
Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet (1988) 1.13
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg (1989) 1.12
Regional lymph node metastases and the level of invasion of primary melanoma. Cancer (1976) 1.08
Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx. Cancer (1985) 1.05
Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg (1989) 1.03
Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg (1985) 1.02
Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91
Prognosis of skin melanoma with regional node metastases (stage II). J Surg Oncol (1984) 0.88
Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients. J Surg Oncol (1988) 0.87
Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg (1990) 0.85
Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. J Clin Oncol (1986) 0.85
Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg Gynecol Obstet (1988) 0.81
Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. Am J Surg (1986) 0.80
Adjuvant chemotherapy combination of vinblastine, actinomycin D, Bleomycin, and Chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor. Cancer (1981) 0.78
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24
Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15
Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90
Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
Cancer phase I clinical trials: efficient dose escalation with overdose control. Stat Med (1998) 4.19
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 3.85
Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77
Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol (1993) 2.71
Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65
Soft tissue sarcomas. Curr Probl Surg (1996) 2.62
Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer (1989) 2.57
The enigma of desmoid tumors. Ann Surg (1999) 2.57
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol (1999) 2.30
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol (1997) 2.10
Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09
Prognosis of pregnancy-associated breast cancer. Cancer (1991) 2.07
Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg (1993) 2.07
Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06
Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05
Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03
Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (1999) 2.03
Surgical management of intra-abdominal desmoid tumours. Br J Surg (2000) 2.01
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clin Cancer Res (2001) 2.01
Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg (1996) 1.97
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood (1989) 1.96
Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination. Arch Surg (1993) 1.94
Adult urological sarcoma. J Urol (1992) 1.94
Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg (1992) 1.92
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.90
Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg (2000) 1.88
Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86
Radiation-associated sarcoma of bone and soft tissue. Arch Surg (1992) 1.84
Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol (2000) 1.83
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol (2004) 1.80
Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol (1998) 1.80
Effect of reresection in extremity soft tissue sarcoma. Ann Surg (2000) 1.80
Uncomplicated starvation versus cancer cachexia. Cancer Res (1977) 1.79
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79
Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg (1991) 1.79
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer (2000) 1.78
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol (1997) 1.77
Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol (1997) 1.75
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg (1997) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.68
The desmoid tumor. Not a benign disease. Arch Surg (1989) 1.66
The role of the pathologist in the management of soft tissue sarcomas. World J Surg (1988) 1.64
Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg (1991) 1.64
An eleven-year experience with adrenocortical carcinoma. Surgery (1992) 1.62
Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg (1994) 1.61
Is gastric carcinoma different between Japan and the United States? Cancer (2000) 1.61
Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg (1987) 1.59
Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest (1988) 1.59
Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors. Ann Surg Oncol (2001) 1.58
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol (1992) 1.58
Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg (1992) 1.57
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
Primary gastrointestinal sarcomas: analysis of prognostic variables. Ann Surg Oncol (1995) 1.56
Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg (1999) 1.54
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res (2000) 1.52
Total parenteral nutrition in the cancer patient. N Engl J Med (1981) 1.52
Wound complications in the multimodality treatment of extremity and superficial truncal sarcomas. J Clin Oncol (1987) 1.51
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50
Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg (1991) 1.50
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Factors predicting hospitalization after operative treatment for gastric carcinoma in patients older than 70 years. J Am Coll Surg (1997) 1.47
Total gastrectomy is not necessary for proximal gastric cancer. Surgery (1998) 1.46
Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res (2000) 1.46
Surgical oncology fellowship: viable pathway to academic surgery? Ann Surg Oncol (1999) 1.46
Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg (1999) 1.45
Intestinal permeability after early postoperative enteral nutrition in patients with upper gastrointestinal malignancy. JPEN J Parenter Enteral Nutr (1999) 1.45
The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg (1987) 1.44
Infarction of the midgut associated with oral contraceptives. Report of two cases. N Engl J Med (1968) 1.43
Laparoscopy in the management of gastric adenocarcinoma. Ann Surg (1997) 1.43
The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42